Back to Dashboard
NVS · Healthcare

Novartis Ag

Europe Healthcare
Market cap
$279.2B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients…

Congressional trades · 44 on record
Disclosures from 2016-03-31 to 2026-03-31
Trade date Member Chamber Action Amount
2026-03-31 Alan Armstrong · R-OK Senate Bought $1,001 - $15,000
2026-03-30 Alan Armstrong · R-OK Senate Bought $15,001 - $50,000
2025-10-31 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-10-30 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-10-30 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-09-25 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-09-11 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-07-22 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-06-17 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-06-11 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
Show the other 34
Trade date Member Chamber Action Amount
2025-06-10 Lisa C. McClain · R-MI House Sold $1,001 - $15,000
2025-06-09 Lisa C. McClain · R-MI House Bought $1,001 - $15,000
2025-03-24 George Whitesides · D-CA House Sold $100,001 - $250,000
2023-07-10 Daniel S. Goldman · D-NY House Sold $50,001 - $100,000
2023-03-31 Daniel S. Goldman · D-NY House Bought $50,001 - $100,000
2023-02-27 Daniel S. Goldman · D-NY House Sold $15,001 - $50,000
2023-01-31 Kevin Hern · R-OK House Sold $1,001 - $15,000
2022-03-16 John H. Rutherford · R-FL House Sold $1,001 - $15,000
2022-02-28 Donald S. Beyer, Jr. · D-VA House Sold $1,001 - $15,000
2022-01-27 Donald S. Beyer, Jr. · D-VA House Bought $1,001 - $15,000
2021-12-22 Donald S. Beyer, Jr. · D-VA House Sold $1,001 - $15,000
2021-09-17 Donald S. Beyer, Jr. · D-VA House Sold $1,001 - $15,000
2020-11-23 Alan S. Lowenthal · D-CA House Sold $1,001 - $15,000
2020-11-23 Alan S. Lowenthal · D-CA House Sold $15,001 - $50,000
2020-11-17 Donald S. Beyer, Jr. · D-VA House Bought $1,001 - $15,000
2020-10-05 Donald S. Beyer, Jr. · D-VA House Sold $1,001 - $15,000
2020-07-27 Kevin Hern · R-OK House Bought $1,001 - $15,000
2020-07-14 Donald S. Beyer, Jr. · D-VA House Sold $1,001 - $15,000
2020-05-07 Donald S. Beyer, Jr. · D-VA House Sold $1,001 - $15,000
2020-05-04 Donald S. Beyer, Jr. · D-VA House Sold $1,001 - $15,000
2020-03-18 Greg Gianforte · R-MT House Bought $1,001 - $15,000
2020-02-20 Mikie Sherrill · D-NJ House Sold $1,001 - $15,000
2020-02-14 Donald S. Beyer, Jr. · D-VA House Bought $1,001 - $15,000
2020-01-27 Donald S. Beyer, Jr. · D-VA House Bought $1,001 - $15,000
2020-01-14 Donald S. Beyer, Jr. · D-VA House Bought $1,001 - $15,000
2019-12-26 Donald S. Beyer, Jr. · D-VA House Bought $1,001 - $15,000
2019-04-08 Jacky Rosen · D-NV Senate Bought $1,001 - $15,000
2019-04-05 Bill Cassidy · R-LA Senate Sold $1,001 - $15,000
2019-01-25 Bill Cassidy · R-LA Senate Bought $1,001 - $15,000
2018-12-07 Bill Cassidy · R-LA Senate Sold $1,001 - $15,000
2018-04-24 Shelley Moore Capito · R-WV Senate Bought $1,001 - $15,000
2017-11-10 Angus S. King, Jr. · I-ME Senate Sold $1,001 - $15,000
2017-09-05 Shelley Moore Capito · R-WV Senate Bought $1,001 - $15,000
2016-03-31 Bill Cassidy · R-LA Senate Bought $1,001 - $15,000
Not in our coverage. Novartis AG isn't currently held by any of the 50 hedge funds we track. The price chart and company profile below come from public Yahoo Finance data.
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell Novartis AG or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime